Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunesis Pharmaceuticals

5.32
+0.0000
Volume:- -
Turnover:- -
Market Cap:27.52M
PE:-0.85
High:5.32
Open:5.32
Low:5.32
Close:5.32
Loading ...
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 12, 2021

Major Issues Report

8-K - Current report
Feb 11, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 12, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jan 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 04, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 22, 2020

Major Issues Report

8-K - Current report
Dec 22, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Dec 07, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 30, 2020

Major Issues Report

8-K - Current report
Nov 30, 2020

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 16, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 16, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Major Issues Report

8-K - Current report
Sep 02, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2020

Major Issues Report

8-K - Current report